These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 14659071
1. Identification of the most accessible sites to ribozymes on the hepatitis C virus internal ribosome entry site. Ryu KJ, Lee SW. J Biochem Mol Biol; 2003 Nov 30; 36(6):538-44. PubMed ID: 14659071 [Abstract] [Full Text] [Related]
2. Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site. Ryu KJ, Lee SW. J Microbiol; 2004 Dec 30; 42(4):361-4. PubMed ID: 15650696 [Abstract] [Full Text] [Related]
3. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Ryu KJ, Kim JH, Lee SW. Mol Ther; 2003 Mar 30; 7(3):386-95. PubMed ID: 12668134 [Abstract] [Full Text] [Related]
6. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus]. Zhang W, Li X, Luo G, Huang Z, Liu Y. Wei Sheng Wu Xue Bao; 2013 Aug 04; 53(8):875-81. PubMed ID: 24341280 [Abstract] [Full Text] [Related]
11. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Macejak DG, Jensen KL, Jamison SF, Domenico K, Roberts EC, Chaudhary N, von Carlowitz I, Bellon L, Tong MJ, Conrad A, Pavco PA, Blatt LM. Hepatology; 2000 Mar 01; 31(3):769-76. PubMed ID: 10706571 [Abstract] [Full Text] [Related]
12. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method. Romero-López C, Barroso-delJesus A, Puerta-Fernández E, Berzal-Herranz A. Biol Chem; 2005 Feb 01; 386(2):183-90. PubMed ID: 15843163 [Abstract] [Full Text] [Related]
15. [Reconstruction of hepatitis D virus ribozymes and their ability to trans-cleave hepatitis C virus RNA]. Yu Y, Mao Q, Li Q, Wang Y, Min F. Zhonghua Gan Zang Bing Za Zhi; 2001 Jun 01; 9(3):157-9. PubMed ID: 11412391 [Abstract] [Full Text] [Related]
17. Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. Lieber A, He CY, Polyak SJ, Gretch DR, Barr D, Kay MA. J Virol; 1996 Dec 01; 70(12):8782-91. PubMed ID: 8971007 [Abstract] [Full Text] [Related]
19. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment. Soler M, McHutchison JG, Kwoh TJ, Dorr FA, Pawlotsky JM. Antivir Ther; 2004 Dec 01; 9(6):953-68. PubMed ID: 15651754 [Abstract] [Full Text] [Related]
20. Investigating a new generation of ribozymes in order to target HCV. Lévesque MV, Lévesque D, Brière FP, Perreault JP. PLoS One; 2010 Mar 10; 5(3):e9627. PubMed ID: 20224783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]